Form SC 13G - Statement of Beneficial Ownership by Certain Investors:
SEC Accession No. 0000814133-23-000015
Filing Date
2023-02-08
Accepted
2023-02-08 13:07:01
Documents
1

Document Format Files

Seq Description Document Type Size
1 nrix223.txt SC 13G 2463
  Complete submission text file 0000814133-23-000015.txt   4045
Mailing Address 505 WAKARA WAY 3RD FLOOR SALT LAKE CITY UT 84108
Business Address 505 WAKARA WAY 3RD FLOOR SALT LAKE CITY UT 84108 8015330777
WASATCH ADVISORS INC (Filed by) CIK: 0000814133 (see all company filings)

EIN.: 870319391 | State of Incorp.: UT | Fiscal Year End: 1231
Type: SC 13G

Mailing Address 1700 OWENS STREET, SUITE 205 SAN FRANCISCO CA 94158
Business Address 1700 OWENS STREET, SUITE 205 SAN FRANCISCO CA 94158 (415) 660-5320
Nurix Therapeutics, Inc. (Subject) CIK: 0001549595 (see all company filings)

EIN.: 270838048 | State of Incorp.: DE | Fiscal Year End: 1130
Type: SC 13G | Act: 34 | File No.: 005-91591 | Film No.: 23598211
SIC: 2834 Pharmaceutical Preparations